APA (7th ed.) Citation

MR, S., MA, F., H, L., & JS, F. (2004). Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: A randomized controlled trial. The Journal of clinical endocrinology and metabolism, 89(8), 3841. https://doi.org/10.1210/jc.2003-032058

Chicago Style (17th ed.) Citation

MR, Smith, Fallon MA, Lee H, and Finkelstein JS. "Raloxifene to Prevent Gonadotropin-releasing Hormone Agonist-induced Bone Loss in Men with Prostate Cancer: A Randomized Controlled Trial." The Journal of Clinical Endocrinology and Metabolism 89, no. 8 (2004): 3841. https://doi.org/10.1210/jc.2003-032058.

MLA (9th ed.) Citation

MR, Smith, et al. "Raloxifene to Prevent Gonadotropin-releasing Hormone Agonist-induced Bone Loss in Men with Prostate Cancer: A Randomized Controlled Trial." The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, 2004, p. 3841, https://doi.org/10.1210/jc.2003-032058.